Price Movement
Volume
Latest volume: 1.26M · 30-day average: 1.35M · Max drawdown over stored range: -42.29%
Research Snapshot
Relative Strength vs SPX
| RS Composite | -32.53% |
| 20D RS | -5.84% |
| 60D RS | -37.02% |
| 120D RS | -41.38% |
| Global RS Rank | 3084 · 8.08% percentile |
| Qualified+ RS Rank | 1185 · 5.80% percentile |
| Group Scope | Qualified+ |
| Primary RS Rank | 93 · 12.26% percentile |
| Snapshot Date | 2026-06-05 |
RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.
Research Links
| StockAnalysis |
| Yahoo Finance |
| Perplexity Finance |
| Finviz |
| Seeking Alpha |
| WhaleWisdom |
| FinanceCharts |
| SEC EDGAR Search |
| SEC Company Search |
Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.
Classification
| Primary Rank | 9 / 185 |
| Primary Percentile | 95.68 |
| Score Notes | market-cap support, industry-tailwind |
Gemini Deep Research
Loading Gemini reports...
Manual Estimates
Loading manual estimates...
Forward Valuation
Loading forward valuation...
SEC TTM Fundamentals
| Period | Filed | Revenue | Gross Profit | Operating Income | Net Income | EPS Diluted | Operating Cash Flow | Capital Expenditure | Free Cash Flow | Shares Diluted | Gross Margin | Operating Margin | Net Margin | OCF Margin | FCF Margin | Cash + ST Inv. | Total Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TTM through 2026-04-03 | 2026-05-05 | 17.26B | n/a | 2.09B | 1.41B | 10.91 | 2.60B | 207.00M | 2.39B | 130M | n/a | 12.09% | 8.19% | 15.03% | 13.83% | 457.00M | n/a |
SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.
TTM Valuation
| Period | EPS Diluted | P/E | Revenue / Share | P/S | FCF / Share | P/FCF Multiple | OCF / Share | P/CF Multiple |
|---|---|---|---|---|---|---|---|---|
| TTM through 2026-04-03 | $10.91 | 11.4x | $133.30 | 0.9x | $18.44 | 6.7x | $20.04 | 6.2x |
Shares Diluted: 130M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.
Financial Statement Metrics
| Metric | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | 13737 | 14396 | 15438 | 16662 | 17174 |
| Revenue Growth (YoY) | 11.71% | 4.797% | 7.238% | 7.928% | 3.073% |
| Gross Profit | 2014 | 2084 | 2244 | 2798 | 3099 |
| Operating Income | 1163 | 1133 | 1302 | 1815 | 2100 |
| Free Cash Flow | 929 | 863 | 980 | 1286 | 1625 |
| Free Cash Flow Per Share | 6.497 | 6.254 | 7.101 | 9.456 | 12.5 |
| EPS (Diluted) GAAP | 5.27 | 4.96 | 1.44 | 9.22 | 11.14 |
| EPS Growth | 20.872% | -5.882% | -70.968% | 540.278% | 20.824% |
| EPS Non-GAAP | |||||
| Gross Margin | 14.661% | 14.476% | 14.536% | 16.793% | 18.045% |
| Operating Margin | 8.466% | 7.87% | 8.434% | 10.893% | 12.228% |
| Profit Margin | 5.482% | 4.758% | 1.289% | 7.526% | 8.431% |
| Free Cash Flow Margin | 6.763% | 5.995% | 6.348% | 7.718% | 9.462% |
| Shares Outstanding (Diluted) | 143 | 138 | 138 | 136 | 130 |
| Shares Change (YoY) | -0.694% | -3.497% | 6700% | -1.449% | -4.412% |
SEC Quarterly Fundamentals
| Quarter | Filed | Revenue | Gross Margin | Operating Income | Op Margin | Net Income | Net Margin | EPS Diluted | Shares Diluted | Cash + ST Inv. | Total Debt | Confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2026-05-05 | 4.38B | n/a | 508.00M | 11.59% | 328.00M | 7.48% | 2.56 | 128.00M | 457.00M | n/a | processed |
| 2025 Q3 | 2025-11-04 | 4.45B | n/a | 535.00M | 12.03% | 367.00M | 8.25% | 2.82 | 130.00M | 974.00M | n/a | processed |
| 2025 Q2 | 2025-08-05 | 4.23B | n/a | 571.00M | 13.49% | 391.00M | 9.24% | 3.01 | 130.00M | 930.00M | n/a | processed |
| 2025 Q1 | 2025-05-06 | 4.23B | n/a | 530.00M | 12.54% | 363.00M | 8.59% | 2.77 | 131.00M | 842.00M | n/a | processed |
| 2025 Q4 | 2026-02-17 | 4.20B | n/a | 473.00M | 11.27% | 327.00M | 7.79% | 2.52 | 130.00M | 1.11B | n/a | processed |
| 2024 Q3 | 2024-10-29 | 4.17B | n/a | 516.00M | 12.38% | 364.00M | 8.73% | 2.68 | 136.00M | 1.19B | n/a | processed |
| 2024 Q2 | 2024-07-30 | 4.11B | n/a | 475.00M | 11.57% | 322.00M | 7.84% | 2.37 | 136.00M | 823.00M | n/a | processed |
| 2024 Q1 | 2024-04-30 | 3.95B | n/a | 415.00M | 10.50% | 284.00M | 7.19% | 2.07 | 137.00M | 633.00M | n/a | processed |
| 2024 Q4 | 2025-02-11 | 4.35B | n/a | 421.00M | 9.68% | 284.00M | 6.53% | 2.09 | 136.00M | 943.00M | n/a | processed |
| 2023 Q4 | 2024-02-13 | 3.95B | n/a | 361.00M | 9.14% | 229.00M | 5.80% | 1.62 | 141.00M | 777.00M | 18.00M | processed |
| 2023 Q3 | 2023-10-31 | 3.90B | n/a | -336.00M | -8.62% | -399.00M | -10.24% | -2.91 | 137.00M | 750.00M | 18.00M | processed |
| 2023 Q2 | 2023-08-01 | 3.81B | n/a | 331.00M | 8.68% | 207.00M | 5.43% | 1.50 | 138.00M | 329.00M | 219.00M | processed |
| 2023 Q1 | 2023-05-02 | 3.68B | n/a | 265.00M | 7.20% | 162.00M | 4.40% | 1.17 | 138.00M | 379.00M | 339.00M | processed |
| 2022 Q4 | 2023-02-14 | 3.66B | n/a | 265.00M | 7.23% | 177.00M | 4.83% | 1.28 | 138.00M | 516.00M | 992.00M | processed |
| 2022 Q3 | 2022-11-01 | 3.58B | n/a | 281.00M | 7.85% | 162.00M | 4.53% | 1.17 | 138.00M | 807.00M | 380.00M | processed |
| 2022 Q2 | 2022-08-02 | 3.57B | n/a | 271.00M | 7.60% | 171.00M | 4.79% | 1.24 | 138.00M | 339.00M | 530.00M | processed |
| 2022 Q1 | 2022-05-03 | 3.48B | n/a | 271.00M | 7.79% | 175.00M | 5.03% | 1.25 | 140.00M | 297.00M | 455.00M | processed |
| 2021 Q4 | 2022-02-15 | 3.46B | n/a | 270.00M | 7.80% | 174.00M | 5.03% | 1.22 | 143.00M | 727.00M | 79.00M | processed |
| 2021 Q3 | 2021-11-02 | 3.45B | n/a | 305.00M | 8.84% | 205.00M | 5.94% | 1.43 | 143.00M | 587.00M | n/a | processed |
| 2021 Q2 | 2021-08-03 | 3.42B | n/a | 269.00M | 7.87% | 169.00M | 4.95% | 1.18 | 143.00M | 338.00M | n/a | processed |
SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.